Design: Under an IRB designed for this purpose, patients who met prior criteria to be approached via the DaVinci Single Site System were counseled and consented to undergo hysterectomy using the SP Platform. Operative time, complications, intra-operative and pathologic findings, and length of stay were then compared to historical data of patients who had undergone a Davinci Single Site Hysterectomy. In addition, cases were recorded in order to explore the ergonomic benefits of the SP system and to lay groundwork to establish a learning program for Gynecologic Surgeons. A total of 75 cases completed with the SP platform were included in the case series. To our knowledge and at the time of this draft, this series represents the largest volume of such cases evaluated worldwide.

Setting: All patients were seen, evaluated, and treated by one surgeon operating at Virtua Voorhees Hospital. Data for the SP cohort was collected from June, 2023 through March, 2024.

Patients or Participants: Patients evaluated in our case series all had been evaluated and consented for Robotic Hysterectomy for benign indications.

Interventions: The cohort patients all underwent Robotic Assisted Hysterectomy with or without BSO using the DaVinci SP platform

Measurements and Main Results: Statistically significant differences were noted in operative time, length of stay, and postoperative complications. Changes in technique which took advantage of elements inherit to the SP platform were found to make progression through the case more efficient over time.

Conclusion: The DaVinci SP Platform is a feasible tool for the completion of hysterectomy for benign indications, It builds on the benefits seen with Single Site Instrumentation, and adds ergonomic capabilities that improve surgical efficiency and are likely reproducible with appropriate training and supervision.